FDA 483 - Essex Institutional Review Board, Inc - March 21, 2011
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Essex Institutional Review Board, Inc. in Lebanon, NJ, revealed significant deficiencies in its review processes for clinical investigations. The IRB failed to ensure adequate board composition, properly assess risks to subjects, include all necessary information in informed consent forms, and comply with safeguards for pediatric studies. Additionally, the firm's meeting minutes were insufficient, and it failed to follow procedures for reporting study suspensions.
ID · fb79fcd3-425e-4d03-bf71-c1bcd9348e23